Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anusha S

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Stem Cells and Development|September 22, 2021
Identification of Predictive Markers for the Generation of Well-Differentiated Human Induced Pluripotent Stem Cell-Derived Kidney OrganoidsZhaoyu Du, Anusha S Shankar, Thierry P P van den Bosch, et al.
Journal of Cancer Research and Clinical Oncology|May 17, 2023
Sclerosing mesenteritis following immune checkpoint inhibitor therapyAndrew G Kuang, Gabriel Sperling, Tom Z Liang, et al.
American Journal of Clinical Oncology|October 30, 2024
The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal ToxicityJay Shah, Andres Caleb Urias Rivera, Irene Jeong-Ah Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2020
Association of Chronic Immune-Mediated Diarrhea and Colitis With Favorable Cancer ResponseFangwen Zou, Hamzah Abu-Sbeih, Weijie Ma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 4, 2021
Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With CancerJake S Jacob, Barbara E Dutra, Victor Garcia-Rodriguez, et al.
Journal of Cancer Research and Clinical Oncology|November 2, 2023
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitorsGabriel Sperling, Malek Shatila, Krishnavathan Varatharajalu, et al.
Gastro Hep Advances|October 27, 2025
Recent Abdominal Surgery as a Risk Factor for Unfavorable Immune-Mediated Colitis OutcomesRohan Ahuja, Malek Shatila, Jay Shah, et al.
Journal of Cancer Research and Clinical Oncology|October 15, 2022
Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignanciesAustin R Thomas, Mostafa Eyada, Miho Kono, et al.
The Indian Journal of Medical Research|August 22, 2025
Prenatal hemoglobinopathy screening & prevention in India: A cross-sectional studyRajat Kumar Agarwal, Rakesh Dhanya, Lalith Parmar, et al.
The Indian Journal of Medical Research|January 11, 2026
Authors' ResponseRajat Kumar Agarwal, Rakesh Dhanya, Lalith Parmar, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Stem Cells and Development|September 22, 2021
Identification of Predictive Markers for the Generation of Well-Differentiated Human Induced Pluripotent Stem Cell-Derived Kidney OrganoidsZhaoyu Du, Anusha S Shankar, Thierry P P van den Bosch, et al.
Journal of Cancer Research and Clinical Oncology|May 17, 2023
Sclerosing mesenteritis following immune checkpoint inhibitor therapyAndrew G Kuang, Gabriel Sperling, Tom Z Liang, et al.
American Journal of Clinical Oncology|October 30, 2024
The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal ToxicityJay Shah, Andres Caleb Urias Rivera, Irene Jeong-Ah Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2020
Association of Chronic Immune-Mediated Diarrhea and Colitis With Favorable Cancer ResponseFangwen Zou, Hamzah Abu-Sbeih, Weijie Ma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 4, 2021
Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With CancerJake S Jacob, Barbara E Dutra, Victor Garcia-Rodriguez, et al.
Journal of Cancer Research and Clinical Oncology|November 2, 2023
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitorsGabriel Sperling, Malek Shatila, Krishnavathan Varatharajalu, et al.
Gastro Hep Advances|October 27, 2025
Recent Abdominal Surgery as a Risk Factor for Unfavorable Immune-Mediated Colitis OutcomesRohan Ahuja, Malek Shatila, Jay Shah, et al.
Journal of Cancer Research and Clinical Oncology|October 15, 2022
Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignanciesAustin R Thomas, Mostafa Eyada, Miho Kono, et al.
The Indian Journal of Medical Research|August 22, 2025
Prenatal hemoglobinopathy screening & prevention in India: A cross-sectional studyRajat Kumar Agarwal, Rakesh Dhanya, Lalith Parmar, et al.
The Indian Journal of Medical Research|January 11, 2026
Authors' ResponseRajat Kumar Agarwal, Rakesh Dhanya, Lalith Parmar, et al.
Pageof 9